This is the latest of a series of very positive testing results for Amplia. The future is looking positive. Bring on the Phase 1 trials in 2020.
Ann: Amplia Therapeutics Reports Lead Candidate Preclinical Data, page-10
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.010(8.70%) |
Mkt cap ! $28.85M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 10.0¢ | $227.4K | 2.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 145120 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 74561 | 1 |
View Market Depth
| Last trade - 15.58pm 04/11/2024 (20 minute delay) ? |
| ATX (ASX) Chart |